Philadelphia gene therapy developer spun out of Temple to raise over $100M via SPAC

Spin out of Temple University and Philadelphia-based gene therapy developer Renovacor, has agreed to merge with a special purpose acquisition company, or SPAC.

Article from the Philadelphia Business Journal